Product Pipeline

Progression Table — 4 records

Therapeutic Area Phase Name Description Indication Recruiting Latest News
ONCOLOGY/PAIN Phase II NanaBis NanoCelle, non‑opioid analgesic, designed to target certain neuropathic pain Cancer Induced Bone Pain No nil
ONCOLOGY/GASTRO Pre‑Clinical NanoCBD NanoCelle antiemetic using a synthetic cannabinoid Chemotherapy Induced Nausea and Vomiting No nil
ANTI‑AGING Pre‑Clinical NC‑SER NanoCelle growth hormone for improving muscle mass and strength Muscular Hypertropy and Weight Loss No nil
ANTI‑AGING Pre‑Clinical NC‑ACI NanoCelle generic repurpose to prevent muscle loss and improve mitochondrial health Sarcopenia and Cellular Biogensis No nil

Updated October 2025.